Skip to content

Wegovy, Metformin Tirzepatide the catch.

Downloadable Weight-Loss Treatment

The No Diet, Diet.’

Wegovy, Metformin Tirzepatide the catch.

Wegovy, Metformin Tirzepatide the catch.

Wegovy, Metformin Tirzepatide the catch. In the ever-evolving world of medical science, discoveries often transcend their original purposes to address pressing health concerns. Metformin, initially designed as a diabetes treatment, and Tirzepatide, an FDA approved injectable medication for regulating blood sugar, are prime examples of this phenomenon. Beyond their roles in diabetes management, these drugs are now making waves as game-changers in the realm of weight loss.

Wegovy, Metformin Tirzepatide the catch.


Metformin, a widely prescribed medication for managing blood sugar levels in individuals with type 2 diabetes, has long been recognised for its potential in aiding weight loss. Although not initially developed as a weight-loss drug, it has garnered attention for its unexpected benefits in this arena.

Wegovy, Metformin Tirzepatide the catch.

Weight Loss Potential

Metformin’s Mechanism: Metformin primarily works by reducing the liver’s production of glucose and improving insulin sensitivity. These effects help stabilise blood sugar levels, but they also have implications for weight management. While the weight loss achieved with Metformin may be modest, typically around 5%, it offers hope for those struggling to shed excess pounds. Some individuals taking Metformin have reported positive outcomes, especially when combined with lifestyle modifications.

Wegovy, Metformin Tirzepatide the catch.

Wegovy FDA Approved

In contrast to Metformin’s accidental weight loss benefits, Wegovy (Semaglutide) represents a purpose-built solution for obesity management. Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist, was approved by the U.S. Food and Drug Administration (FDA) in 2021 as a breakthrough injectable medication for weight loss. Wegovy, Metformin Tirzepatide the catch.

How Wegovy Works… Wegovy’s primary mechanism of action involves suppressing appetite and increasing feelings of fullness. By targeting the brain’s hunger centres, it helps individuals consume fewer calories, leading to significant weight loss.

Clinical trials for Wegovy have yielded remarkable results. Participants in these studies experienced an average weight loss of 15% of their initial body weight over 68 weeks, surpassing the outcomes achieved with many other weight-loss interventions.

Wegovy, Metformin Tirzepatide the catch.

Combining Forces: Metformin and Wegovy

The convergence of Metformin and Wegovy represents a unique approach to weight management. Some healthcare providers are exploring the potential synergies between these two medications, leveraging Metformin’s glucose-regulating effects alongside Wegovy’s appetite control properties. By combining these medications, individuals may benefit from improved blood sugar control, reduced appetite, and enhanced weight-loss results. However, this approach requires careful monitoring and personalised treatment plans to ensure safety and effectiveness.

Wegovy, Metformin Tirzepatide the catch.

A New Player

A new player from Eli Lilly, the pharmaceutical company, is Tirzepatide, due to gain approval in 2024. It has the potential to normalise blood sugar levels in an impressive 81 to 97 per cent of patients—a significant leap compared to its competitors.
While Tirzepatide’s primary role centres around diabetes management, it also emerges as a potent weight-loss ally—a beacon of hope for type 2 diabetes patients grappling with obesity-related complications such as high blood pressure. This medication is recommended for individuals with a body mass index (BMI) exceeding 35, or those unable to use insulin injections.

Wegovy, Metformin Tirzepatide the catch.

Tirzepatide ….

Eli Lilly has extended its ambitions beyond diabetes treatment, actively seeking approval for Tirzepatide for weight-loss treatments within the NHS. Encouragingly, clinical trials hint at Tirzepatide’s potential to achieve weight loss of up to 26 per cent—an impressive stride beyond the approximately 15 per cent achieved by Novo Nordisk’s Wegovy. Tirzepatide is to be marketed under the name Mounjaro in the UK.

Wegovy, Metformin Tirzepatide the catch.

When the Drugs Stop, as they will….

While Metformin, Wegovy, along with Tirzepatide are offering exciting possibilities, it’s crucial to note, however, the indications are that they will cease to work the day you stop taking them. Many people are expected to experience ‘creep’ and ‘regain’ in the months following. So, maybe it will be a lifelong journey, and what if Government funding for the drug is reversed?

Wegovy, Metformin Tirzepatide the catch.

The Solution

The solution being recommended is to combine taking the drugs in-conjunction with the completing of a proven programme such as Oxford Therapeutics ‘My Weigh Less’. The programme incorporates elements that can yield improved outcomes. CBT, for instance, empowers individuals to identify and modify negative thought patterns related to food, body image, and self-esteem. This is crucial for tackling emotional eating, promoting healthier relationships with food, and addressing the psychological underpinnings of weight gain. Oxford Therapeutics psychological programme has been shown to be the perfect partner for Wegovy.

Wegovy, Metformin Tirzepatide the catch.

A Promising Path Forward

In conclusion, while the drugs mentioned above offer a potential avenue for weight loss, it’s essential to acknowledge their limitations. Combining them with psychological support and embracing sustainable lifestyle changes is key to long-term success. Patients must be reminded that their weight-loss journey is unique, and completing a psychological reset programme will help to deliver the desired weight loss expected, and permanently.

As research Continues

As research continues and medical science advances, the future of weight management is looking increasingly promising. However, individuals seeking to embark on weight-loss journeys should approach these medications with caution and in partnership with their doctor, emphasising the importance of holistic care for sustained success.

Diets Can Never Work

Are you tired of trying an endless list of diets that just don’t work? And becoming weary of your efforts, which always result in you regaining all the lost weight? Are you looking for a medically endorsed solution; one based on thousands of hours of clinical experience?  Maybe something that doesn’t involve following a restrictive diet, doing lots of exercise, or having invasive surgery…?

Wegovy, Metformin Tirzepatide the catch.

So, go ahead, relax, and take a few minutes to daydream… What would it be like to be slim and healthy, to be at your target weight? Can you imagine if you never had to go on a diet again, or be afraid of food? What if you were able to enjoy every social event, with the amazing feeling of extra energy, and improved self-esteem?

Wegovy, Metformin Tirzepatide the catch.

Award-Winning Weight-Loss Solution

Read on to find out about our award-winning solution! But first, allow us to introduce ourselves. We are Martin and Marion Shirran, and we have worked in the field of weight loss for almost 20 years. We are both clinical therapists, and the developers of the globally acclaimed Gastric Mind Band Permanent Weight-Loss Treatment.

Martin and Marion Shirran - Wegovy, Metformin Tirzepatide the catch.

Articles about our successful clients have appeared in many different newspapers, including the Daily Mail, The Times, The Telegraph and the Express. Additionally, magazines such as Vogue, Marie Claire, Good Housekeeping, Hello, Woman, Reader’s Digest and Psychologies have featured our work.

Wegovy, Metformin Tirzepatide the catch.

Over a thousand people, including medical professionals, celebrities, and members of the public, have travelled from around the world, to experience our weight-loss treatment. They invested their time and money because we are regarded as specialists in the weight-loss arena. Some clients simply want to shed their excess weight to look better, however others tell us that health is the main reason. Many of our past clients have successfully reversed medical conditions such as insulin resistance, diabetes, high blood pressure, and fatty liver disease, whereas others have managed to avoid having knee, or hip replacement surgery.

Wegovy, Metformin Tirzepatide the catch.

Our weight-loss approach has been the subject of continued research and development over the last thirteen years. Sharon, above, lost 75 pounds. Our youngest client was just fourteen, and the oldest, eighty-six. Some clients wished to lose just a few pounds to fit into their wedding dress. But others, like Sarah, below, went on to lose over 140 pounds. As a result, she was featured globally on the TV and in the press. Follow this link to sign up for our course now, and you can start your weight-loss journey.

Sarah before and after losing weight

Psychology-Focused Weight-Loss Method

The treatment is based on proven science, incorporating Cognitive Behaviour Therapy, Clinical Hypnotherapy and Neuro-Linguistic Programming and Neuroplasticity. It also includes our own Life Architecture Therapy, along with TCBT, our upgraded version of CBT, which is the subject of our bestselling book, published globally by Hay House. Professor Windy Dryden, of Goldsmiths University in London, endorsed the book, and Professor Philip Zimbardo, of Stanford University in the USA, wrote the foreword.

Wegovy, Metformin Tirzepatide the catch.

You can feel comfortable in the knowledge that our weight-loss approach has been the treatment of choice by many different medical specialists, including doctors, dentists, nurses, anaesthetists and consultant surgeons. You may like to read more details on our Medical Endorsements page.

Wegovy, Metformin Tirzepatide the catch.

Wegovy, Metformin Tirzepatide the catch.

So, how would you feel, if you had the opportunity today, to sit down over an ever flowing cup of coffee, with two experienced, weight-loss specialists? And, what if, over the course of 12 hours, we explained everything you need to know to effortlessly achieve permanent weight loss? And we also shared with you all the tips, techniques and secrets we normally reserve exclusively for our visiting international clients?

Martin and Marion Shirran - Wegovy, Metformin Tirzepatide the catch.

Martin and Marion Shirran

Well, the good news is you can! And that’s because we have spent many months completely reformatting our unique, phenomenally successful approach to weight loss. As a result, the course is now instantly available to download to your phone, tablet, or computer. This also means that you can complete the entire course, without having to leave the comfort and security of your own home. Welcome to the ‘My Weigh Less Master Class’!

My Weigh Less - Wegovy, Metformin Tirzepatide the catch.

Read on the pages of this website how the award-winning ‘My Weigh Less’ downloadable treatment is successfully delivering what is surely ‘utopia’ to dieters: a medically endorsed, proven weight-loss approach that provides permanent results! The programme is also based on over 15,000 1:1 clinical treatment hours. My Weigh Less can help you reach your weight-loss goals. Follow this link to sign up for our course now, and you can start your weight-loss journey.

Wegovy, Metformin Tirzepatide the catch.

Wegovy, Metformin Tirzepatide the catch.

My Weigh Less Delivers…

Permanent Weight Loss
– No Diet or Exercise Required –
– Medically Endorsed –
– 15,000 1:1 Clinical Hours Experience –
– Fully Downloadable –
– Featured in Global Media –
– Award-Winning Programme –

Registered Stakeholder in NICE – National Institute for Health and Care Excellence.

Marion Shirran, as a director of Oxford Therapeutics Limited, is proud to be a registered Stakeholder in NICE – National Institute for Health and Care Excellence. Marion is also involved in the government’s All Party Parliamentary Group on Obesity.

My weigh Less

We were proud to be awarded the ‘Most Innovative Obesity Psychological Therapy’ in the UK Mental Health Awards 2022.

Mental Health Awards 2022 "Most Innovative Obesity Psychological Therapy Service"

We also appeared on the This Morning TV show, with Holly Willoughby and Phillip Schofield.

Holly and Phil interviewed Martin and Marion Shirran

And, in 2010, we travelled to New York to be interviewed on the Good Morning America TV Show.

Good Morning America

We are also co-authors of two, bestselling books, about non-surgical weight loss, published by Hay House.

Martin and Marion Shirran
weight loss course

Wegovy, Metformin Tirzepatide the catch.

You can read a full breakdown of all the components included in the treatment package on the Course Details page. There is also an explanation of the treatment on the Does This Work? page. We look forward to working with you. Additionally, you can read reviews from medical and other professionals on the Medical Endorsement page.

View Short Animated Want and Need Video Below

Click on the link below to listen to our short audio introduction of the weight-loss course.

Free Sample Download of My weigh Less

You can download the complete My Weigh Less course, and start your weight-loss journey today.

Register Now for the My Weigh Less Course

Downloadable Weight-Loss Treatment

My Weigh Less®/ and all associated intellectual property rights, are the property of Oxford Therapeutics Limited, a company registered in London.

Oxford Therapeutics Limited with My Weigh Less

You can read additional information about us and our weight-loss treatment on the Gastric Mind Band website.

Although the weight-loss results and success stories shown on the site are typical, individual results will vary, and are not guaranteed. Weight-loss success depends on each individual’s level of motivation, commitment, food intake and metabolism. Read our full disclaimer in the Terms & Conditions.

google-site-verification: googlef6c425f95ce1433a.html

    Your Basket
    Your Basket is emptyReturn to Courses